by Kall Kwik WGC | Apr 3, 2013 | Free Library
April, 2013 SMM-096 The Future of Pharma? Speciation, Sex and Death Having published a 3-year research project and an 80,000 word book on the subject, I am often asked, by pharma executives too impatient to read the whole story, “So, in a...
by Kall Kwik WGC | Apr 3, 2013 | Free Library
March, 2013 SMM-095 The role of product life cycle in medical technology innovation Based on a review of both general and context specific literature in this field, this paper finds that medical technology innovation is strongly influenced by...
by Kall Kwik WGC | Feb 16, 2013 | Free Library
February, 2013 SMM-094 Fitness First As the market changes, existing capabilities become useless and new ones become essential. Professor Brian D Smith describes how pharma companies become fit for the future
by Kall Kwik WGC | Jan 25, 2013 | Free Library
December, 2012 SMM-093 Megatrends that will impact the future of medtech The medical technology sector is being reshaped by fundamental changes that will destroy old business models and demand new capabilities.
by Kall Kwik WGC | Dec 13, 2012 | Free Library
December, 2012 SMM-092 Excellence in market access strategy: A research-based definition and diagnostic tool Market access strategy is a pressing and important issue for almost all pharmaceutical and medical technology companies. Yet the content...
by Kall Kwik WGC | Nov 19, 2012 | Free Library
November, 2012 SMM-091 Access all areas Market Access is a major issue facing innovative medical technology companies. In this article, Professor Brian D Smith reveals the characteristics that differentiate strong market access strategies from...
